Physician profile
David A Dunworth
NPI 1245341635
$140.68
in general payments reported to CMS, 2019-2025
8 companies · $31.48 in 2025
The $31.48 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.32 · 2021: $12.04 · 2022: $34.19 · 2023: $30.07 · 2024: $20.58 · 2025: $31.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $30.07 | 2023 | Puraply |
| Kerecis Limited | $23.74 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $21.88 | 2022 | |
| Advanced Oxygen Therapy INC. | $20.58 | 2024 | Topical Oxygen Chamber For Extremities |
| Tactile Systems Technology INC | $12.32 | 2020 | |
| Ovik Health, LLC | $12.31 | 2022 | |
| Coloplast Corp | $12.04 | 2021 | |
| Reprise Biomedical, INC. | $7.74 | 2025 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dunworth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.